TAG:
dianon systems
Review of 2004 Lab Sales Identifies Buyer Interest
By Robert Michel | From the Volume XII No. 3 – February 14, 2005 Issue
CEO SUMMARY: Laboratory acquisition activity was surprisingly high during 2004. One reason is that new buyers appeared in the marketplace. However, all buyers have specific acquisition criteria. When a selling lab meets that criteria, it can expect multiple bidders and a strong purchase p…
Hey! We Are Halfway Through the 2000’s
By R. Lewis Dark | From the Volume XII No. 2 – January 24, 2005 Issue
WITHOUT SPLITTING HAIRS ABOUT WHETHER THE NEW MILLENNIUM started on January 1, 2000 or January 1, 2001 (although official millennium celebrations heavily favored the former date), I would like to call your attention to an important fact: 2005 is the half-way point in the current decade. Look what ha…
“January 3, 2005 Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume XII No. 1 – January 3, 2005 Issue
More evidence of the move to an all computer economy has surfaced. During 2003, consumer use of credit cards, debit cards, and other electronic payment methods eclipsed paper checks for the first time. The study was done by the Federal Reserve Bank of Atlanta. It reports that 36.7 bi…
Change Beneath Surface Marks 2004 Lab Stories
By Robert Michel | From the Volume XI No. 17 – December 13, 2004 Issue
CEO SUMMARY: Presented here are THE DARK REPORT’S “Ten Biggest Lab Stories of 2004.” These are the events we consider most important to the lab industry during the year. However, in contrast to past years, 2004 lacked the types of blockbuster events which radically change and reshap…
Aureon Biosciences, Bayer, Competitive Technologies, Rare Blood Infections, Kaiser Permanente
By Robert Michel | From the Volume XI No. 16 – November 22, 2004 Issue
KEVIN JOHNSON AND VIJAY AGGARWAL JOIN AUREON BIOSCIENCES TWO VETERAN LAB EXECUTIVES are back in the business. Kevin Johnson is now the Chairman at Aureon Biosciences Corporation and Vijay Aggarwal, Ph.D. is President and CEO. The fact that both men chose to join Aureon Bios…
Oncology’s Potential Drives AP Lab Expansion
By Robert Michel | From the Volume XI No. 12 – August 30, 2004 Issue
CEO SUMMARY: It is no coincidence that another public company is shifting its business focus and expanding its efforts to capture cancer-related anatomic pathology specimens. Demographic trends predict a steady increase in the number of new cancer cases yearly, while new technologies are …
Ex-UroCor Execs Face Criminal Indictments
By Robert Michel | From the Volume XI No. 10 – July 19, 2004 Issue
CEO SUMMARY: Criminal charges filed against ex-UroCor executives center around several marketing practices that have much in common with marketing strategies used by many lab- oratories today. These include discounted pricing for non-Medicare specimens, offering to waive charges to payers…
Digene, Kaiser Northern California, ARUP Labs, Bio-Reference Labs, Specialty Labs
By Robert Michel | From the Volume XI No. 9 – June 28, 2004 Issue
DIGENE ENJOYS GROWTH OF 39% IN RECENT MONTHS FUELED BY RECOGNITION that HPV plays a key role in causing cervical cancer, demand for Digene Corporation’s hc2 High-Risk HPV DNA test is increasing at impressive rates. For fiscal third quarter 2004, Digene reported revenue gr…
National AP Firms Target Gastroenterology Groups
By Robert Michel | From the Volume XI No. 9 – June 28, 2004 Issue
CEO SUMMARY: It’s a trend as yet invisible to the radar screens of most pathology groups. A new crop of specialty AP companies is targeting gastroenterology. In the past 36 months, several have posted phenomenal growth in both specimen volume and revenue. The heightened competition for …
“June 7, 2004 Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume XI No. 8 – June 7, 2004 Issue
Business Week Magazine placed Bio-Reference Laboratories, Inc. (BRLI) on its 2004 list of the Top 100 Hot Growth Stocks. BRLI, based in Elmwood Park, New Jersey, was ranked 16th. Business Week announced the list in its June 7, 2004 issue. With steady growth in reven…
CURRENT ISSUE

Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized